Form 13-F position report

CYTEIR THERAPEUTICS INC

Reported by STATE STREET CORPORATION

CYT CUSIP 23284P103 Manager CIK 0000093751

Reported 0 shares, down 46,153 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2024
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 11 Through Q1 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 1305000
2022-03-31 515000
2022-06-30 71000
2022-09-30 46000
2022-12-31 39357
2023-03-31 43412
2023-06-30 62018
2023-09-30 131075
2023-12-31 140305
2024-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

10 quarters
Quarterly reported position history for CYTEIR THERAPEUTICS INC held by STATE STREET CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2024 Reduced 0 -46,153 (-100.0%) 0 $0 2024-05-15
Q4 2023 Unchanged 46,153 0 (0.0%) < 0.01% $140,305 2024-02-14
Q3 2023 Added 46,153 +22,300 (93.5%) < 0.01% $131,075 2023-11-14
Q2 2023 Unchanged 23,853 0 (0.0%) < 0.01% $62,018 2023-08-14
Q1 2023 Unchanged 23,853 0 (0.0%) < 0.01% $43,412 2023-05-15
Q4 2022 Unchanged 23,853 0 (0.0%) < 0.01% $39,357 2023-02-14
Q3 2022 Unchanged 23,853 0 (0.0%) < 0.01% $46,000 2022-11-15
Q2 2022 Reduced 23,853 -112,657 (-82.5%) < 0.01% $71,000 2022-08-15
Q1 2022 Added 136,510 +21,702 (18.9%) < 0.01% $515,000 2022-05-16
Q4 2021 Added 114,808 +22,917 (24.9%) < 0.01% $1,305,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

40 managers reported CYTEIR THERAPEUTICS INC for Q1 2024.

Managers reporting CYTEIR THERAPEUTICS INC in Q1 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BML Capital Management LLC Added 3,654,053 +404,045 7.25% $10,998,700 5 qtrs
ACADIAN ASSET MANAGEMENT LLC New 26,319 +26,319 < 0.01% $77,000 1 qtr
BOSTON FAMILY OFFICE LLC Unchanged 24,197 0 < 0.01% $73,000 4 qtrs
Lindbrook Capital LLC Unchanged 2,006 0 < 0.01% $6,038 8 qtrs
ROYAL BANK OF CANADA Reduced 0 -5,357 0 $0 6 qtrs
Bank of America Corporation Reduced 0 -89,304 0 $0 12 qtrs
MORGAN STANLEY Reduced 0 -1,000 0 $0 11 qtrs
GABELLI FUNDS LLC Reduced 0 -1,110,050 0 $0 3 qtrs
Laurion Capital Management LP Reduced 0 -316,201 0 $0 8 qtrs
STATE STREET CORPORATION This report Reduced 0 -46,153 0 $0 11 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2024
Filed
May 15, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.